Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Speciality: Oncology
4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini
• 20 May 2021
2:19
European regulation of advanced therapies
Aurélie Mahalatchimy
• 1 Sep 2020
1:58
Cellular therapies: from academia to industry
Jürgen Kuball
• 1 Sep 2020
5:03
Meta-analysis: anti-BCMA CAR-T in R/R myeloma
Nico Gagelmann
• 1 Sep 2020
3:05
Real-world efficacy & safety data: CAR-T in DLBCL
Matthew Frigault
• 1 Sep 2020
1:26
Sharing CAR T-cell data: an EBMT perspective
Jürgen Kuball
• 1 Sep 2020
1:45
Challenges associated with CAR T-cell production
Valentín Ortiz-Maldonado
• 1 Sep 2020
5:43
Gene editing: legal and ethical considerations
Aurélie Mahalatchimy
• 1 Sep 2020
1:35
Gamma delta T-cell therapy
Jürgen Kuball
• 1 Sep 2020
3:39
Future of anti-BCMA CAR T-cell therapy in myeloma
Noopur Raje
• 1 Sep 2020
2:40
The potential of gene-edited effector cell therapy
Maksim Mamonkin
• 1 Sep 2020
2:18
Tocilizumab: CAR T-cell therapy in DLBCL
Matthew Frigault
• 1 Sep 2020
4:18
CAR T-cells: current climate & future perspectives in myeloma
Nico Gagelmann
• 1 Sep 2020
4:28
Selecting DLBCL patients for CAR T-cell therapies
Anna Sureda
• 1 Sep 2020
3:35
Sinusoidal obstruction syndrome in patients with R/R B-cell ALL
Valentín Ortiz-Maldonado
• 1 Sep 2020
6:56
Role of the EBMT registry on reporting CAR T-cell outcomes
Christian Chabannon
• 1 Sep 2020
1
2
Next